Adaptive immune regulation of HSV-2 infection: from acute infection to latency and reactivation
Herpes simplex virus type 2 (HSV-2) establishes lifelong infection through cycles of epithelial replication, neuronal latency, and periodic reactivation. While robust immune responses do not lead to viral clearance, they do play a central role in limiting the tissue impact of ongoing virus shedding that is part of the natural history of HSV-2. In sensory ganglia, CD8 + T cells suppress viral reactivation through non-cytolytic mechanisms, allowing persistence of latent viral genomes. At mucosal sites, tissue-resident memory T cells (TRM cells) provide rapid, localized responses that help contain viral spread. However, HSV-2 replication in epithelial tissues occurs rapidly and can outpace the activation and recruitment of circulating immune cells, creating a temporal mismatch that permits viral shedding despite immune surveillance. These findings suggest that HSV-2 persistence confers a kinetic and spatial advantage over immune responses, underscoring the need for next-generation vaccines and therapeutic strategies that enhance tissue-localized, early immune control and target latent viral reservoirs. This review examines HSV-2 infection as a continuous immunological process across epithelial and neuronal compartments and discusses its implications for vaccine development and therapeutic intervention.
Authors
- Lyle R. McKinnon (ORCID: https://orcid.org/0000-0002-7157-0700)
- Bárbara N. Porto (ORCID: https://orcid.org/0000-0002-1995-9874)
- Melika Verdipanah (ORCID: https://orcid.org/0009-0009-8305-0057)
Institutions
- University of Nairobi (KE)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- University of Manitoba (CA)
Publication Details
- Journal
- Virology
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1016/j.virol.2026.111149
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00